Latest filing published 31 Oct 2023 for Seres Therapeutics, Inc., €3,712.
Filing timeline
BuySaleInsider track record
Paula Cloghessy: trading record in brief
This profile gathers the share dealings of Paula Cloghessy in Seres Therapeutics, Inc. Over a trading history stretching from 5 July 2022 to 30 October 2023, the count stands at 3 filings.
On the market, this insider has only sold: 1 sale, €3,712 in total. The rest of the record consists of 1 share grant and 1 option exercise. So far in 2023, the count stands at no purchases and 1 sale.
On 31 October 2023 came the latest disclosure, an open-market sale for €3,712 in Seres Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Paula Cloghessy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,904 shares@ US$1.353.7% of flowCommon StockSEC:0000899243-23-020082:1
- 9,418 shares0Common StockSEC:0000899243-23-020082:0
- 31,746 shares@ US$3.15100.0% of flowCOMMON STOCKSEC:0000899243-22-025518:0
3 of 3 declarations
